Events /// Investor News /// Investment Case /// Resources
Bayer is committed to providing sustainable solutions that address humanity’s most fundamental needs for essential healthcare and nutritious food. The Bayer Investor Relations Team is dedicated to creating transparency, fostering dialogue, and delivering value to our stakeholders.
Upcoming Events and Highlights
Investor News
Share Price / Index
January 14, 2025
Not intended for U.S. and UK Media
Bayer’s Pharma Growth Strategy Progressing Well as Pipeline Advances
January 13, 2025
Not intended for UK Media
BlueRock Therapeutics advances investigational cell therapy bemdaneprocel for treating Parkinson’s disease to registrational Phase III clinical trial
January 10, 2025
Not intended for U.S. and UK Media
Bayer submits application to U.S. FDA and to China’s CDE for new indication of finerenone for patients with common form of heart failure with high unmet medical need
Discover More
